Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.242
+0.004 (1.77%)
Dec 3, 2024, 1:44 PM EST - Market open
APVO's stock price has decreased by -97.22% in the past year and price targets may not have had time to catch up.
Aptevo Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+3,211.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $8 | Strong Buy | Maintains | $15 → $8 | +3,211.26% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $3,036 → $880 | Buy | Maintains | $3,036 → $880 | +364,138.41% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,816 → $2,200 | Strong Buy | Maintains | $2,816 → $2,200 | +910,496.03% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,408 → $3,036 | Buy | Maintains | $1,408 → $3,036 | +1,256,522.52% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $7,392 | Strong Buy | Initiates | $7,392 | +3,059,502.65% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $4,312 | Buy | Initiates | $4,312 | +1,784,668.21% | Sep 9, 2016 |